Distances From Cricoid Cartilage to the Targets of Stellate Ganglion Block

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.

Verified January 2013 by jong bum Choi, Yonsei University.
Recruitment status was: Recruiting

Sponsor:

Information provided by (Responsible Party):

jong bum Choi, Yonsei University

ClinicalTrials.gov Identifier:

NCT01601925

First received: May 3, 2012

Last updated: January 23, 2013

Last verified: January 2013

History of Changes

Purpose

Stellate ganglion block targets are C6 transverse process or C7 transverse process in anterior paratracheal approach which is most popular method. Cricoid cartilage is known that it is located at C6 level in supine neutral position of the neck. But stellate ganglion block is performed in supine extended position of the neck. So cricoid cartilage will move up to cephalad direction and pain doctors should find C6 or C7 transverse process at lower neck area than cricoid cartilage.

Condition	Intervention
Herpes Zoster CRPS	Other: supine extended position of the neck


Study Type:	Interventional
Study Design:	Intervention Model: Single Group Assignment Masking: Open Label Primary Purpose: Treatment
Official Title:	Distances From Cricoid Cartilage to the Targets of Stellate Ganglion Block

Further study details as provided by jong bum Choi, Yonsei University:

Primary Outcome Measures:

the distances from cricoid cartilage to C6, C7 transverse process in supine neutral and extended position of the neck [ Time Frame: up to 1 week ]
The distances from cricoid cartilage to C6, C7 transverse process will be measured in supine neural position and extended position of the neck up to 1 week after agreement to enroll

Secondary Outcome Measures:

the sexual difference in the distances from cricoid cartilage to C6, C7 transverse process in supine neutral or extended position of the neck [ Time Frame: up to 1 week ]
The sexual difference in the distances from cricoid cartilage to C6,C7 transverse process will be measured in supine neural position and extended position of the neck up to 1 week after agreement to enroll


Estimated Enrollment:	42
Study Start Date:	January 2012
Estimated Study Completion Date:	July 2013
Estimated Primary Completion Date:	June 2013 (Final data collection date for primary outcome measure)

Arms	Assigned Interventions
Experimental: neck extended group We measured the distances from cricoid cartilage to C6 or C7 transverse process in supine neutral and extended position of the neck.	Other: supine extended position of the neck we measure the distances from cricoid cartilage to C6 or C7 transverse process in supine neutral and extended position of the neck

Eligibility


Ages Eligible for Study:	20 Years and older (Adult, Senior)
Sexes Eligible for Study:	All
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

adults above age of 20 reserved for musculoskeletal ultrasonography

Exclusion Criteria:

past history of neck surgery
the limitation of neck motion due to rheumatoid arthritis, et al.
severe neck pain
inability to communicate or read or write

Contacts and Locations

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01601925

Contacts


Contact: Jong B Choi	82-2-2019-6093	romeojb@naver.com

Locations


Korea, Republic of
Gangnam Severance hospital	Recruiting
Seoul, Korea, Republic of

Sponsors and Collaborators

Yonsei University

Investigators


Study Director:	Jong B Choi	Yonsei University

More Information


Responsible Party:	jong bum Choi, Yonsei University College of Medicine, Yonsei University
ClinicalTrials.gov Identifier:	NCT01601925 History of Changes
Other Study ID Numbers:	3-2011-0231
Study First Received:	May 3, 2012
Last Updated:	January 23, 2013

Additional relevant MeSH terms:


Herpes Zoster Herpesviridae Infections DNA Virus Infections Virus Diseases

ClinicalTrials.gov processed this record on June 22, 2017

To Top